Demant turns up outlook after better-than-expected sales
The sales of hearing devices, particularly in Europe, causes Demant to adjust its outlook.
BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN
At this point in time, the growth in revenue for the latter half of 2020 looks better than the Danish hearing aid firm Demant had expected, for which reason the firm upgrades its outlook to 12-14 percent, compared with the former 8-13 percent.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sonova receives FDA approval for new technology
For subscribers
Demant launches new flagship product
For subscribers
